Rebecca Kavanagh, PharmD, BCACP, AAHIVP
Director, Co-Curriculum and Developmental Portfolios
Department of Pharmacy Practice
Touro College of Pharmacy
- Ambulatory Care
- Human Immunodeficiency Virus
- Viral Hepatitis
- Pharm.D., University at Buffalo School of Pharmacy and Pharmaceutical Sciences; 2015
- BA, Psychology, University at Buffalo; 2011
- BS, Biological Sciences with Minor in Pharmacology and Toxicology, University at Buffalo; 2011
- Post-Graduate Year 1 (PGY-1) Pharmacy Residency; The Brooklyn Hospital Center
- Post-Graduate Year 2 (PGY-2) Ambulatory Care Pharmacy Residency; Long Island University at The Brooklyn Hospital Center
Dr. Kavanagh is an Ambulatory Care pharmacy specialist in the Pharmacy Practice department of Touro College of Pharmacy. As the Director of Co-Curriculum and Developmental Portfolios, she is responsible for leading and providing oversight of Touro College of Pharmacy's co-curricular program, overseeing and managing student developmental portfolios, and providing leadership for student involvement in on-campus activities and student organizations. She currently serves as the President of the Royal Counties chapter of the New York State Council of Health-system Pharmacists. She is passionate about providing service to the greater New York community, in particular, underserved patient populations.
Honors and Awards
- Professor of the Year (2019-2020)
- Objective Structured Clinical Examinations
- Programmatic Assessment
- Scholarship of Teaching and Learning
- Cope R, Fischetti B, Kavanagh R, Lepa T, Sorbera M. Safety and Efficacy of Weight‐Loss Pharmacotherapy in Persons Living with HIV: A Review of the Literature and Potential Drug‐Drug Interactions with Antiretroviral Therapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2019; 39(10).Peer reviewed.
- Kavanagh R. Transitioning from passive to active learning in the classroom. Touro College Learning and Teaching Exchange. August 21, 2019.
- Cani E, Park T, Kavanagh R. Chapter 27 - Antiviral Drugs. Side Effects of Drugs Annual. San Diego: Elsevier, 2019; 41:301-319. Peer reviewed.
- Kavanagh R. Chapter 19 - Antihypertensive Drugs. Side Effects of Drugs Annual. San Diego: Elsevier, 2019; 41:219-225. Peer reviewed.
- Kavanagh R., Mitra A. and Basu P. (2020). Biofilms In Healthcare. In: Goldman, E., Green L.H. (Eds), Practical Handbook of Microbiology. 4th Edition. New York, NY: CRC Press (in press). Peer reviewed.
- Kavanagh R. Chapter 20 - Antihypertensive Drugs. Side Effects of Drugs Annual. San Diego: Elsevier, 2020; 42 (in press). Peer reviewed.
- Anderson K, Nocco C, Kavanagh R. New Drug Update: Trogarzo (ibalizumab-uiyk): a novel monoclonal antibody used for salvage therapy in patients living with highly drug-resistant HIV infection. ACCP StuNews. 2019; 38: 4-7.
- Olsufka W, Cabral D, McArdle M, Kavanagh R. Nortriptyline-induced oral ulceration: A case report. Mental Health Clinician: November 2018; Vol. 8, No. 6, 309-312.
- Nguyen T, Kavanagh R. New Drug Update: Edaravone: a free radical scavenger for treatment of amyotrophic lateral sclerosis (ALS) shown to slow the decline in loss of physical function. ACCP StuNews. 2018; 35: 2-3.
- Campbell R, Kufel W. Student Perspective. A.W.N.Y. Express. 2012; January/February: 2015.
- Sharma R, Cani E, Kavanagh R, Seeger A. Assessment of pharmacy student knowledge, attitudes, and perceptions of a co-curriculum program. American Association of Colleges of Pharmacy Virtual Pharmacy Education Conference (July 13 – 31, 2020)
- Marcellus V, Yan T, Diawara O, Kavanagh R. Correlation between virologic suppression and adherence to antiretroviral therapy, and factors that influence this relationship, in an urban primary care clinic. American Society of Health-System Pharmacists Mid-Year Conference; Anaheim, CA (December 5, 2018)
- Choudhury T, Kumar S, Duong T, Kavanagh R. Role of self-monitoring blood glucose in improving hemoglobin A1c levels in non-insulin dependent patients with type 2 diabetes: a systematic review. American Society of Health-System Pharmacists Mid-Year Conference; Anaheim, CA (December 5, 2018)
- Weiss B, Cammarano A, Kavanagh R. Evaluation of GLP-1 agonists: a promising second line therapy to reduce cardiovascular outcomes in type 2 diabetes. American Society of Health-System Pharmacists Mid-Year Conference; Anaheim, CA (December 5, 2018)
- Marfo A, Rakhamimova A, Berger D, Kavanagh R. Safety and immunogenicity of nucleic acid HIV vaccines: a systematic review. American Society of Health-System Pharmacists Mid-Year Conference; Anaheim, CA (December 4, 2018)
- Hernandez N, Donatien C, Flores M, Sow M, Kavanagh R. Evaluation of Cholesterol Control in People Living with HIV. New York Society of Health-System Pharmacists Residents Conference at LIU Pharmacy; Brooklyn, NY (June 22 2018)
- Cabral R, McArdle M, Olsufka W, Kavanagh R. Nortriptyline-induced oral ulcers: a case report. College of Psychiatric and Neurologic Pharmacists Conference; Indianapolis, IN (April 22 2018)
- Campbell R, Kim E. Working beyond the single-disease state model: optimizing use of ambulatory care pharmacists in the primary care setting through use of collaborative drug therapy management agreements. American Society of Health-System Pharmacists Mid-Year Conference; New Orleans, LA (Dec 9 2015)
- Campbell R, Slazak E. Patient adherence to osteoporosis medications in a patient centered medical home. American Society of Health-System Pharmacists Mid-Year Conference; Anaheim, CA (Dec 10 2014)
Service to the College of Pharmacy:
- Director of Co-Curriculum and Developmental Portfolios
- Co-Curriculum & Developmental Portfolios Committee Chair
- Assessment Committee Vice Chair
- Curriculum Committee Member
- Task Force on Committee Structure Member
- Learning Outcomes Committee Member
Service to the Greater Touro College and University System:
- TCOP/Touro College of Dental Medicine Immunization Campaign
- Touro College of Osteopathic Medicine Community Service Committee Member
- Touro College and University System Online Education Task Force Member
Service to the Community:
- Amida Care Pharmacy and Therapeutics Committee Member
- NYC Department of Health & Mental Hygiene’s “Take the Pressure Off, NYC!” Committee Member
- Royal Counties Society of Health-system Pharmacists President and Delegate
- New York State Council of Health-system Pharmacists (NYSCHP)
- Education and Professional Development Committee Member, Student Sub-Committee Member
- Grassroots Advocacy Committee Member
- PHPN 682 (Therapeutics II)
- PHPN 722 (Comprehensive Patient Care Management)
- PHPN 751 (Comprehensive Self Care)
- PHPN 637 (Physical Assessment)
- PHPN 694 (Advanced Diabetes Management Elective)
- PHPN 733 (Pharmacy Practice Seminars)
- PHPN 855 (Pharmacy Practice Primers)